Clincosm LogoSign in Get a demo

sarcoma

Showing 26 - 50 of 618
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose

Not yet recruiting
  • Cancer
  • +16 more
  • KVA12123 - Dose Escalation
  • +3 more
  • (no location specified)
Feb 2, 2023

Sarcoma, Epithelioid Sarcoma, Cutaneous Angiosarcoma Trial in Stanford, New York (Talimogene Laherparepvec (T-VEC),

Recruiting
  • Sarcoma
  • +2 more
  • Stanford, California
  • +1 more
Feb 2, 2023

Sarcoma, Osteosarcoma, Neuroblastoma Trial run by the NCI (Anti-GD2-CAR engineered T cells, AP1903, Cyclophosphamide)

Completed
  • Sarcoma
  • +3 more
  • Anti-GD2-CAR engineered T cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

NIH Intramural Research Program Clinical Protocols

Enrolling by invitation
  • Breast Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Sarcoma, Soft Tissue Sarcoma, Bone Sarcoma Trial in Boston (Aspirin 325mg, Enoxaparin 40Mg/0.4mL Prefilled Syringe)

    Enrolling by invitation
    • Sarcoma
    • +6 more
    • Aspirin 325mg
    • Enoxaparin 40Mg/0.4mL Prefilled Syringe
    • Boston, Massachusetts
      Santiago Lozano-Calderon
    Jan 20, 2023

    Sarcoma, Ewing, Sarcoma Trial in Santa Monica (Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus

    Active, not recruiting
    • Sarcoma, Ewing
    • Sarcoma
    • Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus (MPS)
    • Santa Monica, California
      Sarcoma Oncology Research Center
    Jan 19, 2023

    Molecular Testing for MD Anderson Cancer Center Personalized

    Recruiting
    • Glioma
    • +4 more
    • Biospecimen Collection
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    Solid Tumor, Colorectal Cancer, Gastric Cancer Trial in United States (IGM-8444, FOLFIRI, Bevacizumab (and approved

    Recruiting
    • Solid Tumor
    • +7 more
    • Duarte, California
    • +11 more
    Jan 6, 2023

    Abductor Reattachment Methods in Proximal Femur Replacements:

    Recruiting
    • Sarcoma
    • +2 more
    • Proximal Femur Replacement
    • Durham, North Carolina
      Duke University
    Jan 3, 2023

    Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

    Completed
    Has Results
    • Ovarian Cancer
    • +7 more
    • Enapotamab vedotin (HuMax-AXL-ADC)
    • Phoenix, Arizona
    • +40 more
    Dec 12, 2022

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

    Active, not recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +20 more
    • Pembrolizumab
    • Ziv-Aflibercept
    • Tampa, Florida
    • +8 more
    Jan 3, 2023

    Genomic Structural Variation in Cancer Susceptibility

    Active, not recruiting
    • Breast Cancer
    • +5 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Dec 23, 2022

      Gastric Cancer, Renal Cell Carcinoma, Melanoma Trial in United States (HFB200301)

      Recruiting
      • Gastric Cancer
      • +8 more
      • Scottsdale, Arizona
      • +9 more
      Dec 22, 2022

      Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

      Active, not recruiting
      • Advanced Cancer
      • +16 more
      • Scottsdale, Arizona
      • +3 more
      Dec 22, 2022

      Sarcoma, Sarcoma Metastatic Trial in Ann Arbor (Olaparib, Trabectedin)

      Active, not recruiting
      • Sarcoma
      • Sarcoma Metastatic
      • Ann Arbor, Michigan
        University of Michigan Rogel Cancer Center
      Dec 20, 2022

      Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)

      Recruiting
      • Neuroblastoma
      • +2 more
      • Columbus, Ohio
        Nationwide Children's Hospital
      Dec 20, 2022

      Cancer, Cancer of Pancreas, Sarcoma Trial (STI-1386)

      Not yet recruiting
      • Cancer
      • +4 more
      • (no location specified)
      Dec 15, 2022

      Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

      Recruiting
      • Clinical Stage I Cutaneous Melanoma AJCC v8
      • +33 more
      • Informational Intervention
      • +4 more
      • Los Angeles, California
      • +4 more
      Dec 14, 2022

      Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Virtual group based physical activity (BurnAlong) and Social Media

      Recruiting
      • Cancer
      • +21 more
      • Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Dec 7, 2022

      Melanoma, Neuroblastoma, Sarcoma Trial in New York (124I-Humanized 3F8)

      Active, not recruiting
      • Melanoma
      • +2 more
      • 124I-Humanized 3F8
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Dec 1, 2022

      Sarcoma Trial in Shanghai (MASCT-I,PD1 Antibody,Apatinib)

      Active, not recruiting
      • Sarcoma
      • MASCT-I,PD1 Antibody,Apatinib
      • Shanghai, Shanghai, China
        Shanghai Sixth People's Hospital
      Nov 22, 2022

      Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in United States (Isolated Limb Infusion, Pembrolizumab,

      Recruiting
      • Sarcoma
      • +3 more
      • Isolated Limb Infusion
      • +2 more
      • Basking Ridge, New Jersey
      • +6 more
      Nov 21, 2022

      Sarcoma Trial in Houston (Autologous HER2-specific T cells, Fludarabine, Cyclophosphamide)

      Active, not recruiting
      • Sarcoma
      • Autologous HER2-specific T cells
      • +3 more
      • Houston, Texas
      • +1 more
      Nov 21, 2022

      Sarcoma, Malignant Mesenchymoma, Sarcoma of Bone and Connective Tissue Trial in Heidelberg

      Recruiting
      • Sarcoma
      • +2 more
        • Heidelberg, Baden-Württemberg, Germany
          National Center for Tumour Diseases, University Hospital Heidelb
        Nov 21, 2022

        Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)

        Recruiting
        • Nasopharyngeal Carcinoma
        • +8 more
        • Springdale, Arkansas
          Highlands Oncology
        Nov 11, 2022